Skip to main content

Table 2 Pairwise comparison of glucose-control measurements and metabolic parameters after 3 months of treatment with liraglutide

From: An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes

 

Baseline (mean ± SD)

Month 3 (mean ± SD)

p-value

HbA1c (mmol/mol)

68 ± 16

56 ± 14

<0.001

MBG (mmol/L)

10.8 ± 2.4

9.1 ± 2.0

<0.001

FPG (mmol/L)

10.7 ± 4.1

7.9 ± 2.1

<0.001

TG (mmol/L)

2.7 ± 3.7

1.7 ± 1.2

<0.01

HDL (mmol/L)

1.0 ± 0.2

0.9 ± 0.2

NS

LDL (mmol/L)

3.0 ± 1.1

2.6 ± 0.6

NS

TC (mmol/L)

5.1 ± 1.2

4.3 ± 0.7

<0.001

  1. FPG fasting plasma glucose, HbA1c haemoglobin A1c, HDL high-density-lipoprotein cholesterol, LDL low-density-lipoprotein cholesterol, MBG mean blood glucose, NS not significant, SD  standard deviation, TC total cholesterol, TG triglycerides
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us